Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Ni

Showing results (521-530 of 541) with videos related to

Pageof 55
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 29, 2021
Joint Genome-Wide Association Analyses Identified 49 Novel Loci For Age at Natural MenopauseLei Zhang, Xin-Tong Wei, Jun-Jie Niu, et al.
Cancer Research|May 16, 2018
Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade GliomasSharmistha Pal, David Kozono, Xiaodong Yang, et al.
Singapore Medical Journal|February 11, 2025
Knowledge, attitudes and perceptions of advance care planning among specialist healthcare professionals in neurology, neuro-oncology and surgeryZheting Zhang, Jing Ni Ng, Felicia Jin Yee Sie, et al.
International Journal of Surgery (London, England)|May 28, 2025
Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysisYandong Miao, Jian Gan, Yan-Jing Ni, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Changli Qian, Erica Holdridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain MetastasesSheheryar Kabraji, Jing Ni, Sarah Sammons, et al.
Nature Communications|May 4, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Yadong Zhang, Changli Qian, et al.
Immunologic Research|September 14, 2022
An association study on the risk, glucocorticoids effectiveness, and prognosis of systemic lupus erythematosus: insight from mitochondrial DNA copy numberZhen Li, Qi-Qun Zong, Chun-Xia Zhai, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 1, 2010
[Identification of the active material of anti-hepatic fibrosis from Amydae Carapax]Jian-rong Gao, Yan-wen Liu, Chang-yu Li, et al.
Pageof 55

Showing results (521-530 of 541) with videos related to

Sort By:
Pageof 55
The Journal of Clinical Endocrinology and Metabolism|May 29, 2021
Joint Genome-Wide Association Analyses Identified 49 Novel Loci For Age at Natural MenopauseLei Zhang, Xin-Tong Wei, Jun-Jie Niu, et al.
Cancer Research|May 16, 2018
Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade GliomasSharmistha Pal, David Kozono, Xiaodong Yang, et al.
Singapore Medical Journal|February 11, 2025
Knowledge, attitudes and perceptions of advance care planning among specialist healthcare professionals in neurology, neuro-oncology and surgeryZheting Zhang, Jing Ni Ng, Felicia Jin Yee Sie, et al.
International Journal of Surgery (London, England)|May 28, 2025
Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysisYandong Miao, Jian Gan, Yan-Jing Ni, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Changli Qian, Erica Holdridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain MetastasesSheheryar Kabraji, Jing Ni, Sarah Sammons, et al.
Nature Communications|May 4, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancerXin Cheng, Yadong Zhang, Changli Qian, et al.
Immunologic Research|September 14, 2022
An association study on the risk, glucocorticoids effectiveness, and prognosis of systemic lupus erythematosus: insight from mitochondrial DNA copy numberZhen Li, Qi-Qun Zong, Chun-Xia Zhai, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 1, 2010
[Identification of the active material of anti-hepatic fibrosis from Amydae Carapax]Jian-rong Gao, Yan-wen Liu, Chang-yu Li, et al.
Pageof 55